NCT02282605

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

A Phase I/II Randomised, Double-blind, Placebo-controlled, Single Centre Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of Two Concentrations of XF-73 Nasal Gel in Healthy Subjects.

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Destiny Pharma Plc · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

Study to determine the efficacy, safety and tolerability of two concentrations of XF-73 nasal gel in combination with body and face washing with chlorhexidine gluconate cloths in eradicating nasal carriage of Staphylococcus aureus.

Conditions

• Staphylococcus Aureus Infection

Interventions

Type	Name	Description
DRUG	XF-73 nasal gel
DRUG	Placebo nasal gel
OTHER	Chlorhexidine gluconate 2% topical cloths

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2014-11-04
• Last updated: 2016-10-07
• Results posted: 2016-10-07

Locations

1 site across 1 country: United Kingdom